Normally to get this kind of potential growth you have to buy a bio with a drug in phase 1 or 2 and losing 60m a year. Being able to buy a PE10 company making billions of profit is just jaw dropping.
Standard and Poor's fair value: 181 !!!!
Yes, you read that right.
S&P’s “fair values”
S&P Capital IQ on TDAmeritrade
Stock……….current price………”fair value” __fv/pr
Sentiment: Strong Buy